Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,765 | -67,593 | -41,275 | -41,863 | -18,128 |
| Depreciation Amortization | 4,535 | 20,062 | 14,959 | 9,948 | 4,931 |
| Accounts receivable | 7,935 | -5,020 | 1,553 | -2,113 | -230 |
| Accounts payable and accrued liabilities | -3,858 | -3,259 | -5,756 | -6,266 | -6,289 |
| Other Working Capital | 611 | -41,593 | -40,221 | -23,485 | -11,219 |
| Other Operating Activity | -6,868 | 58,002 | 41,699 | 36,309 | 13,775 |
| Operating Cash Flow | $-15,410 | $-39,401 | $-29,041 | $-27,470 | $-17,160 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,900 | -26,108 | -19,824 | -19,381 | 4,457 |
| PPE Investments | -265 | -2,360 | -1,881 | -700 | -395 |
| Purchase Of Investment | N/A | N/A | -29,226 | -28,573 | N/A |
| Sale Of Investment | 0 | 158 | 158 | 159 | 160 |
| Purchase Sale Intangibles | N/A | -1,173 | -1,162 | N/A | N/A |
| Other Investing Activity | 0 | -1,174 | -1,162 | 1 | 1 |
| Investing Cash Flow | $-6,165 | $-29,484 | $-51,935 | $-48,494 | $4,223 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,395 | -5,379 | -3,986 | -2,598 | -1,247 |
| Common Stock Issued | 30 | 44 | N/A | N/A | N/A |
| Other Financing Activity | -3,535 | -11,426 | -8,635 | -5,763 | -2,843 |
| Financing Cash Flow | $-4,900 | $-16,761 | $-12,621 | $-8,361 | $-4,090 |
| Exchange Rate Effect | -217 | 3,928 | 2,588 | 883 | 1,412 |
| Beginning Cash Position | 61,533 | 143,251 | 143,251 | 143,251 | 143,251 |
| End Cash Position | 34,841 | 61,533 | 52,243 | 59,809 | 127,636 |
| Net Cash Flow | $-26,692 | $-81,718 | $-91,008 | $-83,442 | $-15,615 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,410 | -39,401 | -29,041 | -27,470 | -17,160 |
| Capital Expenditure | -265 | -2,360 | -1,881 | -700 | -395 |
| Free Cash Flow | -15,675 | -41,761 | -30,922 | -28,170 | -17,555 |